AbelsonTaylor
Independent
Address
433 W. Van Buren St.
Chicago, Illinois 60602
Year Founded
1981
Full-time Employees
284
North American Revenue 2022
Full-time Employees 2022
Number of clients 2022
Offices
North America
1
Locations
Chicago, IL
Executives & Senior Management
Dale Taylor
CEO
Jeff Berg
President
Jay Carter
EVP, Director of Business Development
Senior Management
Dale Taylor CEO
Agency 100 T-Shirt
Capabilities/Services Offered
Professional Consumer OTC Direct Marketing Media Planning Med-Tech Data/Analytics Digital
New Services
AT initiated a broad development plan to significantly increase our marketing intelligence integration into our clients marketing plans. We have designed and implemented a streamlined data aggregation platform that enables multitouch attribution modeling and performance benchmarking for our clients across both NPP and sales. As part of our MI development, we have also deployed rapid experimentation, audience personalization and dynamic content optimization in our clients digital marketing mix; all dramatically increasing the ability of our clients to meet there goals at a greater efficiencies.
New Roles
Roles Added 10 Roles Lisa Brigham - Director of Talent Acquisition
Client Roster
Aerovate Therapeutics AV-101 Arcutis Biotherapeutics ARQ-154 Arcutis Biotherapeutics Zoryve Astellas Pharma AmBisome Astellas Pharma Anti-Infective Franchise Astellas Pharma Cresemba Avanos Coolief Biogen-Sage Zuranolone City of Hope City of Hope Comprehensive Cancer Center Coherus Cimerli Coherus Udenyca Cooper Medical Fertility CooperSurgical ALLY CooperSurgical EndoSee CooperSurgical Insorb CooperSurgical Mara CSL Behring Acquired Bleeding Global CSL Behring Afstyla Global CSL Behring Afstyla US CSL Behring CSL312 CSL Behring Haegarda CSL Behring Haemate-P US CSL Behring HEMGENIX CSL Behring Hizentra CIDP Global CSL Behring Hizentra CIDP US CSL Behring Hizentra PI US CSL Behring Idelvion Global CSL Behring Idelvion US CSL Behring Kcentra CSL Behring Privigen Global CSL Behring Privigen PI/ITP CSL Behring VWD Global Fresenius Kabi Idacio Global Fresenius Kabi Idacio US Fresenius Kabi Toci Global Fresenius Kabi Toci US G1 Therapeutics Cosela Karyopharm Therapeutics Xpovio Neurocrine Biosciences Ingrezza DTC/HCP Neurocrine Biosciences Ingrezza HD Pharmacosmos Monoferric PharmaEssentia BESREMi Sage Therapeutics 718 Seres Therapeutics/Aimmune Therapeutics SER-109 Takeda Pharmaceuticals Motegrity Vericel Maci Vericel Nexobrid
Growth
2022 Growth from Existing Clients
25%
2022 Growth from New Clients
15%
Creative Samples